Pedicures are already the standard of care for many people, and now a company in Germany is hoping to revolutionize the way they are delivered, by creating a new type of implant that will deliver a specially formulated cocktail of hormones to treat a variety of conditions.
The company, called Moxil, aims to deliver a special cocktail of hormone cocktails to the skin on the face, and to other areas in the body, which is said to reduce the risk of developing certain cancers.
The hormone cocktail will also be able to be injected directly into the body to treat the conditions such as diabetes and breast cancer.
According to the company, the injections are made of a new compound called metacam, which, when combined with a cocktail of growth factors, is able to produce a high-performance form of implant.
The treatment is a relatively new idea in the field of healthcare, but there have been some success stories.
In 2015, a woman in the US, who had been prescribed metacams for her breast cancer, was able to start her treatment.
She is currently on chemotherapy for her condition, and has already seen improvement in her skin.
The idea is not new to the medical field, and it has been used to treat numerous conditions in the past, including psoriasis and eczema, which has been treated with a variety, including metacamprosin.
According Moxibac, the idea is to make the hormone cocktails easier to administer.
“The injection procedure is very painful, so we have developed a method that does not involve the needle.
Instead, the pills are inserted in a needle,” the company said in a statement.
The hormone cocktails, according to the statement, are designed to be inserted directly into patients’ bodies.
It is estimated that the new implant will cost between $250,000 and $350,000.
It is still unclear whether the company will actually launch its device in Germany.